Evoke Wealth’s CONMED CNMD Stock Holding History

Evoke Wealth’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-16	Closed	-$1.54K	–	1287
2019 Q3	$1.54K	Buy	+16	New	+$1.5K	﹤0.01%	1255

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Evoke Wealth's CNMD Position: Q4 2019 in Review

Evoke Wealth sold out of CONMED (CNMD) in Q4 2019, closing a stake of 16 shares — an estimated $1.54K sold.

Evoke Wealth first reported a position in CNMD in Q3 2019 and held it in 1 quarter. The position peaked at $1.54K in Q3 2019. 264 funds tracked by Wall St. Rank hold CNMD as of Q4 2019.

Evoke Wealth reported no remaining CONMED position as of Q4 2019 after selling out during the quarter.
Evoke Wealth sold 16 CONMED shares in Q4 2019, an estimated $1.54K.
Evoke Wealth first reported a position in CONMED in Q3 2019 and held it in 1 quarter.
Evoke Wealth's CONMED position peaked at $1.54K in Q3 2019.
264 funds tracked by Wall St. Rank held CONMED as of Q4 2019.

Based on Evoke Wealth's 13F filing for Q4 2019, filed 7 Feb 2020.